Skip to content

A study comparing how well Articaine and Lignocaine work to numb the upper jaw during dental implant procedures.

Efficacy Of 4 percent Articaine Vs 2 percent Lignocaine in achieving anesthesia following infiltration during implant placement in maxilla A randomized controlled study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/086327
Enrollment
40
Registered
2025-05-05
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K081- Complete loss of teeth

Interventions

Intervention1: ARTICAINE: Articaine hydrochloride is an amide local anesthetic, 4-methyl-3 (2 [propylamino] propionamido)-2-thiophenecarboxylic acid, methyl ester hydrochloride. It is unique among a

Sponsors

Dr Soniya Sawakare
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Dental implant placement in maxillary arch 2) Single or multiple dental implant surgeries. 3) Signature of informed consent form

Exclusion criteria

Exclusion criteria: 1. Pregnancy, lactation, and taking contraceptive pills. 2. Oversensitivity or anaphylactic reactions which contraindicate the intervention. 3. Known allergies 4. Orofacial neurological symptoms. 5. Infections at the operation zone. 6. Psychotropic medicine, sedative, or NSAID use which can alter the sense of pain 7. Pathological mental conditions (dementia, psychosis) and lack of cooperation. 8. Advanced surgical necessities (GBR, split crest, vertical regeneration, block graft, etc.) 9. Operations carried out with conscious sedation. 10. Patients who do not want to sign consent. of interest.

Design outcomes

Primary

MeasureTime frame
a.Visual Analogue Scale b.Verbal pain intensity scale Timepoint: 3rd and 7th day

Secondary

MeasureTime frame
1) Evaluate time required for the onset and duration of anesthesia. 2) Pain perception during infiltration and during surgery. 3) Need for second time anesthesia. 4)Amount of solution used [measured in ml] 5)Pain at the injection site (3rd and 7th day)Timepoint: Pain will be evaluated at injection site at 3rd and 7th day.

Countries

India

Contacts

Public ContactDR MONALI SHAH

K M Shah Dental College And Hospital

smonali2011@gmail.com9824003228

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026